Ketogenic Intervention in Depression
NCT06080932 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2025-05-29
Summary
The goal of this study is to examine whether a well-formulated ketogenic diet (KD) can be implemented into a university counseling treatment program for major depression and to test whether such a program has any benefit on mental and metabolic health.
Conditions
- Depression
- Ketosis
Interventions
- OTHER
-
Ketogenic Diet
The diet intervention will start after all baseline testing is complete
- OTHER
-
NIH Toolbox
IPAD-based assessments that examines cognitive function
- OTHER
-
gradCPT
The gradCPT contains grayscale photographs of mountain scenes and city scenes. Scene images gradually transition from one image to the next
- OTHER
-
Resting-state fMRI
Whole brain echo-planar imaging (EPI) volumes sensitive to the BOLD signal will be acquired. Images will be re-aligned, un-warped, and normalized. Confounding effects of white matter, CSF signal, and head motion will be regressed from the functional time series, followed by bandpass filtering, linear detrending and smoothing, and whole brain resting state networks will be identified (e.g., default mode network, salience network, etc).
- OTHER
-
Task-fMRI
During whole brain EPI data acquisition, participants will be presented with words and pictures and asked to make judgements about the stimuli, such as indicating whether a particular stimulus (e.g., face-name association, word, number, or letter) has been previously presented, if a presented stimulus is a city or mountain scene, the direction an arrow is pointing (left or right), if a pair of stimuli match (e.g., faces with neutral or emotional expressions; word with a face). Behavioral responses will be recorded with an MRI compatible button box.
- OTHER
-
CGM/CKM
Continuous Ketone/Glucose Monitor will be applied at the start of Test Day 1. The sensor will be checked by the study team at each test day and will be removed and replaced by a fresh sensor at \~2- week intervals during the study. The sensor will be removed at the end of the final test day.
- BIOLOGICAL
-
Blood Draw
Blood samples will be collected according to the schedule in Figure 1
- OTHER
-
Sleep Monitoring
Sleep will be assessed by ring-based acceleration with cloud technology (Oura Ring). This monitor is less burdensome than other sleep monitoring technologies and less likely to interfere with normal sleep and activity demands. Worn daily throughout intervention
- BIOLOGICAL
-
Ketone/Glucose Monitoring
KetoMojo hand-held glucometer will be used daily to monitor dietary intervention adherence.
- OTHER
-
Body Composition
DEXA Scanning will be done pre-, mid-, and post- intervention.
- BEHAVIORAL
-
PHQ-9
It is a self-assessment tool used to screen and assess the severity of depression in individuals. The PHQ-9 consists of nine questions based on the nine criteria for diagnosing major depressive disorder in the Diagnostic and Statistical Manual of Mental Disorders (DSM-5).
- BEHAVIORAL
-
WHO-5
The WHO-5, also known as the World Health Organization-Five Well-Being Index, is a self-assessment tool used to measure subjective well-being and mental health. It was developed by the World Health Organization (WHO) as a brief and reliable instrument to evaluate well-being in clinical and research settings.
- BEHAVIORAL
-
SKID
The SKID refers to the Structured Clinical Interview for DSM Disorders (SCID). It is a widely used diagnostic tool in the field of psychiatry and clinical psychology. The SCID is a semi-structured interview designed to assess and diagnose various mental disorders according to the criteria outlined in the Diagnostic and Statistical Manual of Mental Disorders (DSM), which is published by the American Psychiatric Association.
Sponsors & Collaborators
-
Ohio State University
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 30 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-02-20
- Primary Completion
- 2024-06-01
- Completion
- 2024-12-21
Countries
- United States
Study Locations
More Related Trials
-
Heart Disease Risk Factors in Major Depression
NCT00001969 ·Status: COMPLETED
-
Exploring Clinical Study Experiences of People With Depression
NCT05937932 ·Status: NOT_YET_RECRUITING
-
Diet and Depression
NCT06252701 ·Status: COMPLETED ·Phase: NA
-
Meditative Neurofeedback for Depression
NCT06675240 ·Status: RECRUITING ·Phase: NA
-
The Effect of Mediterranean Diet and Mindfulness Eating on Depression Severity in People With Obesity and Major Depressive Disorder
NCT06621394 ·Status: RECRUITING ·Phase: NA
-
A Study of Ketamine Infusions to Treat Clinically-depressed ICU Patients
NCT05803551 ·Status: RECRUITING ·Phase: PHASE2
-
Precision Care for Major Depressive Disorder
NCT06580041 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE4
-
Can the Memory Support Intervention Improve Depression Outcome Following Cognitive Therapy?
NCT02938559 ·Status: COMPLETED ·Phase: NA
-
Cognitive Training for Depression
NCT01936506 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effect of Intranasal Insulin on Depressive Symptoms in Major Depressive Disorder
NCT00570050 ·Status: COMPLETED ·Phase: PHASE3
-
Role of Inflammation Factors and Insulin Resistance in Major Depressive Disorder
NCT01699490 ·Status: UNKNOWN ·Phase: PHASE4
-
Organized Self-Management Support Services for Chronic Depression
NCT01139060 ·Status: COMPLETED ·Phase: PHASE3
-
Studying Patterns in Patient Engagement Among Treatment Resistant Depression Patients
NCT06101914 ·Status: NOT_YET_RECRUITING
-
Training Doctors to Support Patient Self-Care of Depression
NCT01618552 ·Status: COMPLETED ·Phase: NA
-
Functional and Metabolic Changes in the Course of Antidepressive Treatment
NCT02099630 ·Status: COMPLETED
-
Effects of Treatment on Decision-making in Major Depression
NCT01916824 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of Cortisol Administration on Neural Correlates of Emotion in Depression
NCT02837432 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
RESISTance Exercise for Depression Trial
NCT06110897 ·Status: RECRUITING ·Phase: NA
-
The Relations Among Endotoxin, Inflammatory Cytokines, Cognitive Markers and Brain MRI Changes in Subjects With Depressive Disorder
NCT06203015 ·Status: RECRUITING
-
Magnesium Sulfate Versus 5% Dextrose With Treatment Resistant Depression
NCT01597167 ·Status: COMPLETED ·Phase: NA
-
Examining Cognitive Mechanisms of Clinical Improvement Following Mindfulness Based Therapy for Depressed Individuals
NCT02457936 ·Status: COMPLETED ·Phase: NA
-
Cognitive Training for Depression II
NCT01934491 ·Status: COMPLETED ·Phase: NA
-
Feasibility of Resistance Exercise to Treat Major Depression Via Cerebrovascular Mechanisms
NCT05695365 ·Status: COMPLETED ·Phase: NA
-
Slow-wave Sleep Deprivation in Depression
NCT01189591 ·Status: COMPLETED ·Phase: NA
-
Neurocognitive Enhancement in Major Depressive Disorder
NCT00998569 ·Status: COMPLETED ·Phase: NA